Article Details
Retrieved on: 2021-07-22 00:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
"Pfizer has begun to see progress in the overall biosimilars marketplace in the U.S.," the company said. "However, changes in policy at a government ...
Article found on: www.law360.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here